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Background: It is indicated that non-HDL cholesterol and lipid ratios, including total/HDL cholesterol and LDL/HDL
cholesterol ratios, are risk indicators with greater predictive value for coronary atherosclerotic progression or
regression compared with conventional lipid profile. However, there have been few reports about the correlation
between serum lipid profile with carotid intima-media thickness (IMT) and plaque in Chinese general people.
Methods: We examined 402 subjects without apparent diseases in a cross-sectional study (mean age 50.16 years;
36.07% female). Demographics, anthropometrics, and laboratory data were collected. The presence of carotid
plaque and intima-media thickness were evaluated by ultrasonography.
Results: Univariate correlations showed carotid IMT was correlated with LDL-C (r = 0.137, p = 0.009), non-LDL-C
levels (r = 0.140, p = 0.008) and LDL-C/HDL-C ratio (r = 0.169, p = 0.001). After adjustment for potential covariates,
LDL-C/HDL-C ratio (β = 0.132, p < 0.001) were independent variables that interacted on carotid IMT. Other risk
factors including age and systolic blood pressure were independently associated with carotid IMT. LDL-C levels,
non-HDL-C levels, TC/HDL-C and LDL-C/HDL-C ratios were significantly higher, but HDL-C levels were significantly
lower in subjects with carotid plaque than those without it. The subsequent multiple logistic regression analysis
showed that LDL-C (OR; 1.325, 95% CI; 1.046-1.821, p = 0.033) and HDL-C levels (OR; 0.093, 95% CI; 0.038-0.227, p < 0.001)
were significantly associated with the presence of carotid plaque after adjustment of age. Furthermore, LDL-C
combined with HDL-C levels showed the highest area under the curve (0.788, 95% CI; 0.740–0.837, p < 0.001).
Conclusions: Serum LDL-C/HDL-C ratio represents as an independent index associated with increased carotid IMT
and LDL-C combined with HDL-C levels may be useful markers for predicting the presence of carotid plaque in
the Chinese general population.
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Atherosclerosis is the primary cause of mortality and
morbidity in cardiovascular disease (CVD) [1]. Dyslip-
idemia is the most important risk factor for athero-
sclerosis and contributes to increased risk to develop
CVD. Previous studies have demonstrated that low-
density lipoprotein (LDL) is the primary atherogenic
lipoprotein [2,3] and that high-density lipoprotein (HDL)
is the predominant anti-atherosclerotic lipoprotein [4].
Therefore, measurements of total cholesterol (TC), HDL
cholesterol (HDL-C), and LDL cholesterol (LDL-C) are
widely recommended [5]. Recent data suggested that* Correspondence: tianyp61@gmail.com
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unless otherwise stated.non-HDL cholesterol (non-HDL-C) is a better param-
eter for assessing CVD risk rather than TC and HDL-C
[6-9]. Also, some studies suggested that lipid ratios,
including TC/HDL-C and LDL-C/HDL-C ratios are risk
factors with better predictive value for coronary athe-
rosclerotic progression or regression than each lipid
parameter used independently [10-14]. However, data
comparing the role of non-HDL-C and these lipid ratios
with conventional lipid profile in early-stage athero-
sclerotic changes are limit.
Atherosclerosis develops silently over decades before
symptoms eventually occur. Carotid ultrasonography
can be used to noninvasively identify early-stage athero-
sclerotic changes in arterial wall. Measurements of
intima-media thickness (IMT) and detection of plaqued. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tors for early-stage atherosclerosis [15,16].
In the present study, we investigated associations be-
tween conventional lipid parameters and lipid ratios
with carotid IMT and plaque in participants of a health
checkup from the general population.
Methods
Study population enrollment
Study subjects were randomly recruited from individuals
who visited the Health Medical Center of PLA General
Hospital for a health checkup from January 2014 to May
2014. All participants underwent a routine clinical exam-
ination including physical examination, blood biochemical
examination and carotid ultrasonography. Those who
had history of CVD, diagnosed atherosclerosis (carotid
IMT > 1.4 mm), diabetes or uncontrolled hypertension
were excluded. After the screening of consecutive 524 sub-
jects according to the inclusion and exclusion criteria, a
total of 402 subjects were finally enrolled. Written informed
consent was obtained from participants and the ethics com-
mittee of PLA General Hospital approved present study.
Demographic and clinical characteristics
Demographic and clinical characteristics such as age,
gender, history of CVD, hypertension or current anti-
hypertension therapy, and diabetic mellitus were ob-
tained by the means of structured questionnaire. Blood
pressures were measured by trained nurses using an
automatic digital sphygmomanometer. Height, weight,
waist circumference, hip circumference was measured
manually. Body mass index (BMI) was calculated as
weight (kilograms) divided by height (meters) squared.
Laboratory examination
Fasting venous blood samples were collected from each
participant and transferred to center laboratory in
30 minutes. Triglyceride (TG), TC, LDL-C, HDL-C, cre-
atine kinase (CK), high sensitivity C-reactive protein
(hs-CRP) and fasting blood glucose were measured by
Automatic Biochemistry Analyzer (Roche, model c501,
Sweden) after samples were centrifuged at 1500 g for
10 minutes. Glycosylated hemoglobin A1c(HbA1c) was
measured in red blood cells using ion-exchange high-
performance liquid chromatography (Sysmex, G8, Japan).
Carotid ultrasonography
Carotid ultrasound examination was performed by the
expert sonographers who were blinded to the partici-
pant’s clinical characteristics. Both the left and right
carotid arteries were evaluated using high-resolution
B-mode ultrasound scanners (Phillips, HD7, USA)
equipped with a 7.5 MHz high-resolution linear array
transducer (Phillips, L12-3, USA). The common carotidartery, carotid bulb, and internal carotid artery were
carefully scanned from continuous angles to identify the
thickest carotid IMT and plaque lesions. Intima-media
thickness was defined as the distance between the lead-
ing edge of the lumen-intima and the leading edge of
the media adventitia echo. Mean value of the three
determinations was calculated and the final values of
IMT were averaged by the left and right mean IMT
values. Plaque was defined as a focal thickening of at
least 50% greater than that of the surrounding vessel
wall with a minimal thickness of at least 1.3 mm.
Statistical analysis
Data are given as mean ± standard deviation (SD) or per-
centage. The Kolmogorov- Smirnov test was used to
determine the normality of distributions and non-Gaussian
distributed variables were log transformed (ie, TG). Linear
correlations between carotid IMT (dependent variable)
with lipid parameters and clinical characteristics (inde-
pendent variable) were evaluated by Pearson correlation
or Spearman rank correlation as appropriate. A stepwise
multiple regression analysis was also performed to
examine determinant factors for carotid IMT. The final
model was determined using Pin < 0.05 and Pout < 0.10.
Standardized coefficient (β) and P values are presented.
The data were compared by the φ2-test or the Student’s
t-test between the groups with and without carotid
plaques. Next, multiple logistic regression models were
constructed (Pin < 0.05 and Pout < 0.10) to elucidate the
independent determinants of carotid plaque. The odds
ratio and 95% confidence interval of each factor are
given. Receiver operating characteristic (ROC) analysis
was also performed to determine the ability of each lipid
parameter to detect carotid plaque. Areas under the
ROC curves (AUC) and 95% confidence intervals were
calculated. All analyses were performed by SPSS statis-
tical software (Version19.0, SPSS Inc). P values of <0.05
were considered statistically significant.
Results
Clinical characteristics
Baseline characteristics and clinical parameters of total sub-
jects are shown in Table 1. The median age of participants
was 50.16 years and about one-third (36.07%) of partici-
pants were female. Mean levels of total cholesterol, triglyc-
erides, HDL-C, and LDL-C were 4.76 mmol/L, 1.86 mmol/L,
1.29 mmol/L and 3.10 mmol/L, respectively. Median
levels of CK and hs-CRP were 110.62 U/L and 0.15 mg/dL,
respectively. The prevalence of carotid plaque was 27.4%.
Correlation between carotid IMT and lipid parameters
and other variables
In univariate correlation analysis (Table 2), carotid IMT
was significantly correlated with age, LDL-C, non-LDL-
Table 1 Clinical characteristics (n = 402)
Variables Mean ± SD or percentage
Gender, female (%) 145 (36.07)
Age (years) 50.16 ± 8.19
BMI (kg/m2) 25.40 ± 3.41
WHR 0.89 ± 0.08
SBP (mmHg) 124.04 ± 15.42
DBP (mmHg) 82.83 ± 11.44
Fasting blood glucose (mmol/L) 5.85 ± 1.10
HbA1C (%) 5.90 ± 0.67
CK (U/L) 110.62 ± 71.24
Hs-CRP (mg/dL) 0.15 ± 0.12
TC (mmol/L) 4.76 ± 0.83
TG (mmol/L) 1.86 ± 1.49
HDL-C (mmol/L) 1.29 ± 0.33
LDL-C (mmol/L) 3.10 ± 0. 80
Carotid IMT (mm) 0.84 ± 0.20
Presence of carotid plaque (%) 110 (27.40)
Abbreviations: BMI body mass index, WHR waist-to-hip ratio DBP diastolic blood
pressure, SBP systolic blood pressure, TC serum total cholesterol, TG serum
triglycerides, HDL-C serum high-density lipoprotein cholesterol, LDL-C serum
low-density lipoprotein cholesterol, CK creatine kinase, Hs-CRP high sensitivity
C-reactive protein, IMT intima-media thickness.

















TC/HDL-C ratio 0.087 0.099
LDL-C/HDL-C ratio 0.169 0.001
Gender: Male = 1, female = 0.
Abbreviation: NI not included in the model.
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p = 0.008, p = 0.001). Carotid IMT was also correlated
with gender, systolic blood pressure, HbA1C, CK, and
total cholesterol levels (p = 0.043, p = 0.029, p = 0.024,
p = 0.044, p = 0.017). However, there was no significant
correlation between IMT and the other variables includ-
ing triglycerides, HDL-C levels, TC/HDL-C ratio and
hs-CRP levels.
Subsequently, stepwise multiple regression analysis
was performed using 4 lipid parameters (TC, LDL-C,
non-LDL-C, and LDL-C/HDL-C) and 5 other variables
(gender, age, SBP, HbA1C, and CK) with a significance
level <0.05 in previous simple correlation analysis as
independent variables. As a result, age, systolic blood
pressure, LDL-C and LDL-C/HDL-C ratio were finally
included in the model as independent variables that
interacted on carotid IMT (Table 2). LDL-C/HDL-C
ratio was more strongly correlated with carotid IMT than
LDL-C (β = 0.132, p < 0.001 vs. β = 0.099, p = 0.030). No
association was seen between non-HDL-C and carotid
IMT in the multivariate regression model.
Associations between lipid parameters, other variables
and the presence of carotid plaque
As shown in Table 3, age, systolic blood pressure, LDL-C
and non-HDL-C levels, TC/HDL-C and LDL-C/HDL-C
ratios were significantly higher, but HDL-C levels were
significantly lower in subjects with carotid plaque than
those without it. There was no significant differences and other variables
Multivariate

















Table 3 Associations between lipid parameters, other variables and the presence of carotid plaque
Variables Plaque(+) (n = 110) Plaque(−) (n = 292) p-value
G/ender, female (%) 35 (31.82) 110 (37.67) 0.276
Age (years) 53.75 ± 7.67 47.46 ± 7.54 <0.001
BMI (kg/m2)WHR 25.49 ± 3.620.90 ± 0.08 25.34 ± 3.240.89 ± 0.08 0.7430.205
SBP (mmHg) 126.46 ± 15.89 122.21 ± 14.84 0.029
DBP (mmHg) 83.66 ± 11.68 82.19 ± 11.26 0.310
Fasting blood glucose (mmol/L) 5.95 ± 1.10 5.76 ± 1.10 0.176
HbA1C (%) 5.99 ± 0.67 5.84 ± 0.67 0.079
CK (U/L) 115.82 ± 88.99 106.70 ± 54.20 0.311
Hs-CRP (mg/dL) 0.16 ± 0.13 0.14 ± 0.12 0.092
TC (mmol/L) 4.87 ± 0.88 4.68 ± 0.78 0.070
TG (mmol/L) 1.96 ± 1.55 1.78 ± 1.45 0.324
HDL-C (mmol/L) 1.21 ± 0.28 1.35 ± 0.35 0.001
LDL-C (mmol/L) 3.22 ± 0. 85 3.01 ± 0. 76 0.042
Non-HDL-C (mmol/L) 3.65 ± 0.88 3.32 ± 0.76 0.002
TC/HDL-C ratio 4.19 ± 1.16 3.65 ± 1.00 <0.001
LDL-C/HDL-C ratio 2.74 ± 0.81 2.37 ± 0.80 <0.001
Mean IMT (mm) 0.84 ± 0.20 0.82 ± 0.16 0.410
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parameters such as percentage of female, BMI, WHR,
HbA1c, CK, hs-CRP levels as well as the other lipid
parameters such as total cholesterol and triglyceride
levels.
Multiple logistic regression analysis was then performed
using the presence of carotid plaque as the dependent
variable, and using age, LDL-C and HDL-C levels as inde-
pendent variables. The presence of carotid plaque was
significantly and independently predicted by LDL-C (OR;
1.325, 95% CI; 1.046-1.821, p = 0.033) and HDL-C levels
(OR; 0.093, 95% CI; 0.038-0.227, p < 0.001) after adjust-
ment of age (Table 4).
Receiver operating characteristic analysis was also per-
formed to test the accuracy of each of the 7 lipid param-
eters as well as the combination model including LDL-C
and HDL-C levels for predicting the presence of carotid
plaque. ROC curves are shown in Figure 1. The AUC-
values for TC/HDL-C (0.685, 95% CI; 0.627–0.743, p <
0.001) and LDL-C/HDL-C ratios (0.683, 95% CI; 0.624–
0.742, p < 0.001) were significantly higher than those for
TC (0.565, 95% CI; 0.496–0.625, p = 0.037) and triglycerideTable 4 Logistic regression model for prediction of the
presence of carotid plaque
Variables Odds ratio 95% CI p-value
Age 1.121 1.082-1.161 <0.001
HDL-C 0.093 0.038-0.227 <0.001
LDL-C 1.325 1.046-1.821 0.033
Abbreviation: CI confidence interval.levels (0.533, 95% CI; 0.496–0.570, p = 0.086), and relatively
higher than those for HDL-C (0.657, 95% CI; 0.601–0.713,
p < 0.001), non-HDL-C (0.641, 95% CI; 0.577–0.706, p <
0.001) and LDL-C levels (0.596, 95% CI; 0.531–0.662,
p = 0.003). The combination model showed the largest
area under the curve (0.788, 95% CI; 0.740–0.837, p <
0.001), which was significantly higher than the AUC-
value of each lipid parameter separately used.
Discussion
Although preventable, atherosclerotic cardiovascular
disease remains a leading global cause of death and dis-
ability. Causal risk factors for cardiovascular disease
constitute important therapeutic targets, but their use-
fulness as predictors for the disease developing is lim-
ited. Most heart attacks and strokes occur in people at
average risk-factor level who are misclassified by trad-
itional risk factor scoring, as low or intermediate risk
[17]. Therefore, the only effective approach to restrict
the health burden is to prevent the diseases from devel-
oping at the earliest possible stage of atherosclerosis.
Thus, screenings for biomarkers for detecting early-
stage asymptomatic vascular atherosclerotic changes
are needed.
Our present study indicated that the combined appli-
cation of LDL-C and HDL-C was superior to separate
lipid parameters for assessing the risk of early-stage
atherosclerosis in apparently healthy people from the
general population. Carotid IMT appeared to be more
closely correlated with LDL-C/HDL-C ratio compared
with LDL-C level even after adjustment of age. Also,
Figure 1 ROC curves of lipid parameters and the combination model including LDL-C and HDL-C levels for predicting the presence of
carotid plaque.
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the prevalence of carotid plaque. Furthermore, AUC-
values for LDL-C/HDL-C and TC/HDL-C ratios were
higher than those for the other lipid parameters and
LDL-C combined with HDL-C level showed the highest
area under the curve.
Low-density lipoprotein cholesterol transports chol-
esterol from the liver to peripheral tissues and advances
the foaming of macrophages via uptake within the
arterial wall. Conversely, high-density lipoprotein stim-
ulates the efflux of excess cellular cholesterol and
reversely transports it to the liver. High-density lipo-
protein also protects against atherosclerosis by inhibit-
ing cytokine-induced expression of endothelial cell
adhesion molecules. According to these known mecha-
nisms, it is no wonder that lipoprotein ratios, which
indicate the proportion between the atherogenic and
protective lipoproteins, have greater predictive power
for assessing the extent of lipid accumulation in the ar-
terial wall or the severity of atherosclerotic intimal
changes.
Some studies have suggested that TC/HDL and LDL-
C/HDL-C ratios are risk indicators for CVD with greater
predictive value than each parameter used independently
[10-14]. Furthermore, Katakami et al. [18] combined
conventional lipid profile and lipid ratios to detect early-
stage atherosclerosis in type 2 diabetic patients and
noted that TC/HDL-C and LDL-C/HDL-C ratios can be
good risk indicators for early-stage atherosclerosis, evenif the conventional lipid parameters are within normal
range. However, there were limit studies that investi-
gated the effects of lipids and lipid ratios on early-stage
atherosclerosis in general population. Kinosian et al.
[14] reported that TC/HDL-C ratio or LDL-C/HDL-C
ratio was superior to either TC level or LDL-C level for
identifying general people at greater risk of developing
subsequent coronary heart disease events. Tamada et al.
[19] revealed that serum LDL-C/HDL-C ratio was
independently associated with increased carotid plaque
score and may represent a useful marker for evaluating
the extent of atherosclerosis in the early stages in the
general population compared with LDL-C alone. Coin-
cidently, our results in multiple linear regression
showed LDL-C/HDL-C ratio contributed to increased
carotid IMT.
Recently, non-high-density lipoprotein cholesterol
(non-HDL-C) has become increasingly recognized as an
important index of atherogenic particles, as it reflects
the cholesterol in all lipoprotein particles that are
considered to be atherogenic. Non-HDL-C has been
reported to be strongly associated with predicting
coronary artery disease [6-9]. There also have been
several reports about the association between non-
HDL-C level and subclinical atherosclerosis in type 2
diabetic subjects [20-24]. Most of those studies noted
that non-HDL-C level was a better predictor of carotid
IMT than isolated lipid parameters, even TC/HDL-C
ratio. However, according to our study, non-HDL-C
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early-stage atherosclerosis. The negative result may be
attributable to the fact that our study population com-
prised numerous low-risk participants with relatively
steady baseline non-HDL-C level than CVD patients.
Further studies with a larger sample size are needed to
avoid possible bias.
High sensitivity C-reactive protein (hs-CRP), a widely
used marker of inflammation, was associated with
neither carotid IMT nor presence of carotid plaque in
this study. Hs-CRP has shown to be associated with
cardiovascular disease events in most, but not all studies
[25-27]. Our results indicate that routine use of hs-CRP in
general people may not improve assessment for early-stage
atherosclerosis, in accordance with Virani et al. [23].
The present study has several limitations. Firstly, this
is a cross-sectional study with a relatively small number of
subjects. Given the cross-sectional nature of our study,
only associations can be drawn between LDL-C/HDL-C
ratio and carotid early-stage atherosclerosis. But the asso-
ciations do not necessarily indicate causality. Secondly,
although we tried to minimize possible influence of known
major confounders, the detailed information of smoking
status (a known CVD risk factor) in study subjects were
not available. The unmeasured factor may leave room for
residual bias in multiple regression analysis. Moreover, the
results may have been confounded by unknown factors.
Thus, target LDL-C/HDL-C for management as a primary
preventive strategy in early-stage atherosclerosis cannot be
established from the present results. Further prospective
cohort studies with a larger sample size are needed.
Conclusions
Serum LDL-C/HDL-C ratio represents as an independent
index associated with increased carotid IMT and LDL-C
combined with HDL-C levels may be useful markers for
predicting the presence of carotid plaque in the Chinese
general population.
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